Recent Health Care Deals, week ending 07.22.2016
AcquirerTargetPrice Celgene CorporationCollaboration on immuno-oncology drugs$225 million Santen Pharmaceutical Co. Ltd.InnFocus Inc. $225 million Zimmer Biomet HoldingsMedtech SA$132.9 million Janssen BiotechLicense to IONIS-JBI1-2.5Rx$10 million Center Management Group, LLCAssisted living community$4.25... Read More »Recent Health Care Deals, week ending 07.15.2016
AcquirerTargetPrice Nichi-Iko Pharmaceutical Co. Lt.d Sagent Pharmaceuticals Inc. $736 million Thoma Bravo LLCImprivata, Inc. $544 million Evolent Health, Inc. Valence Health, Inc. $145 million PGIM Real EstateSolana Willistown & Solana Roseland$98.25 million LTC Properties, Inc. Village at Athens$14.3... Read More »Recent Health Care Deals, week ending 07.08.2016
AcquirerTargetPrice Bio-Techne Corporation Advanced Cell Diagnostics$250 million Merit Medical Systems, Inc.DFINE, Inc.$97.5 million Bristol-Myers SquibbCormorant Pharmaceuticals AB$95 million Takeda Pharmaceutical Co. Ltd.License to Cx601$27.7 million Advantage Benefit SolutionsCollins Benefits Solutions,... Read More »Recent Health Care Deals, week ending 07.01.2016
AcquirerTargetPrice Medtronic plcHeartWare International, Inc. $1.1 billion Mayne Pharma42 generic drugs from Teva$652 million Baptist HealthFloyd Memorial Hospital and Health Services$276 million Teladoc, Inc. HealthiestYou Corporation$152.9 million Novartivs AGLicense to 2 Xencor drug candidates$150... Read More »Recent Health Care Deals, week ending 06.24.2016
AcquirerTargetPrice Impax Laboratories Inc.15 generic drugs from Teva$586 million Kindred HealthcareHome health & hospice offices in Arkansas$39 million Magic Software Enterprises Ltd. Roshtov Software Industries$21 million Retrophin Inc. Rights to ursodeoxycholic acid$500,000 Schweiger Dermatology GroupDr. Frank Demento's dermatology... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
